This extension does NOT authorize the collection of data. The extension is only designed to give NIH a couple of months to send in a more complete package. Extension of the current ICR does not constitute concurrence with the design of the proposed Phase II study. We will review Phase II on its own merits once the package arrives.
The program will resubmit after substantially rewriting both portions of the supporting statement. The rewrite will include discussion of the broader context within which this project sits (Phase I, II, and III of the initiative) and tie it to the prior approval. The rewrite will provide more detail as to the sample design and the degree to which the design meets the goals of second phase of the project. The incentive section will be re-written in line with OMB guidelines. This submittal should be done as a substantive change, but no additional FR notice is required.
Inventory as of this Action
Requested
Previously Approved
01/31/2009
07/31/2010
09/30/2008
2,637
0
479
1,305
0
434
0
0
0
NIDA seeks to assess the effectiveness of the Brain Power! materials to stimulate interest in scientific learning about the biology of the brain and neurobiology of drug addiction and to lay the foundation for drug abuse prevention.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.